![spacer](../images/spacer.gif)
![The Healthcare Sales & Marketing Network](../images/hsmn_logo_trans_R_300.png)
![The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community. The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.](../images/27years_3bs.png)
![Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines](../images/connecting_caret.png)
![Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines](../images/connecting_caret.png)
Searching News Database: Cardiac Output
HSMN NewsFeed - 5 May 2017
Ram Group Announces Breakthrough in Non-Invasive Cardio-Pulmonary Monitoring Wearables
Ram Group Announces Breakthrough in Non-Invasive Cardio-Pulmonary Monitoring Wearables
HSMN NewsFeed - 22 Dec 2014
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
HSMN NewsFeed - 12 Nov 2014
Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP)
Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP)
HSMN NewsFeed - 4 Dec 2013
Getinge Intends to Acquire Hemodynamic Monitoring Leader Pulsion Medical Systems
Getinge Intends to Acquire Hemodynamic Monitoring Leader Pulsion Medical Systems
HSMN NewsFeed - 20 Nov 2012
Sunshine Heart Receives Unconditional FDA Approval for C-Pulse(R) System's U.S. Pivotal Trial
Sunshine Heart Receives Unconditional FDA Approval for C-Pulse(R) System's U.S. Pivotal Trial
HSMN NewsFeed - 1 Oct 2012
Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse(R) Heart Assist System
Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse(R) Heart Assist System
HSMN NewsFeed - 6 Aug 2012
Sunshine Heart Announces Conditional Approval From FDA for Its Next Generation C-Pulse(R) System Driver
Sunshine Heart Announces Conditional Approval From FDA for Its Next Generation C-Pulse(R) System Driver
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 14 Mar 2012
Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data
Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data
HSMN NewsFeed - 7 Nov 2011
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
HSMN NewsFeed - 8 Sep 2011
FDA Grants Fluke Biomedical 510(k) Clearance for New ProSim(TM) Vital Signs Simulators
FDA Grants Fluke Biomedical 510(k) Clearance for New ProSim(TM) Vital Signs Simulators
HSMN NewsFeed - 12 Oct 2010
Italian Man Surpasses 1,000 Days of Support with SynCardia’s Total Artificial Heart
Italian Man Surpasses 1,000 Days of Support with SynCardia’s Total Artificial Heart
HSMN NewsFeed - 29 Sep 2010
Sunshine Heart(R) to Develop Smaller Next Generation Controller for Its C-Pulse(R) Heart Assist System
Sunshine Heart(R) to Develop Smaller Next Generation Controller for Its C-Pulse(R) Heart Assist System
HSMN NewsFeed - 8 Sep 2010
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
HSMN NewsFeed - 7 Sep 2010
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
HSMN NewsFeed - 23 Mar 2010
OrSense Receives U.S. FDA Approval for NMB-200MP Non-Invasive Oximetry Monitoring System
OrSense Receives U.S. FDA Approval for NMB-200MP Non-Invasive Oximetry Monitoring System
HSMN NewsFeed - 26 Aug 2009
Spacelabs Healthcare Expands International Distribution of USCOM Cardiac Output Monitor
Spacelabs Healthcare Expands International Distribution of USCOM Cardiac Output Monitor
HSMN NewsFeed - 9 Jun 2009
SonoSite Announces Plans to Acquire CardioDynamics - A Cardiovascular Disease Management Company
SonoSite Announces Plans to Acquire CardioDynamics - A Cardiovascular Disease Management Company
HSMN NewsFeed - 21 Apr 2009
First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
HSMN NewsFeed - 9 Sep 2008
MicroMed Cardiovascular Purchased and Taken Private by Artificial Heart CEO and Some SynCardia Investors
MicroMed Cardiovascular Purchased and Taken Private by Artificial Heart CEO and Some SynCardia Investors
HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
HSMN NewsFeed - 27 Feb 2008
Biophan Announces Appointment of Jeanne Lesniak as Advisor for Regulatory and Clinical Affairs for Myotech
Biophan Announces Appointment of Jeanne Lesniak as Advisor for Regulatory and Clinical Affairs for Myotech
HSMN NewsFeed - 22 Jan 2008
FDA Approves Cheetah Reliant(TM) for Noninvasive Cardiac Output Monitoring (NICOM(R))
FDA Approves Cheetah Reliant(TM) for Noninvasive Cardiac Output Monitoring (NICOM(R))
HSMN NewsFeed - 7 Nov 2007
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 18 Jul 2007
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 19 Apr 2007
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 20 Mar 2007
St. Jude Medical Announces FDA Approval of First U.S. Heart Failure Device with AF Suppression Technology
St. Jude Medical Announces FDA Approval of First U.S. Heart Failure Device with AF Suppression Technology
HSMN NewsFeed - 6 Mar 2007
Breaking Study: Masimo Blue Sensor Shown to Be Most Accurate in Monitoring Cyanotic Infants
Breaking Study: Masimo Blue Sensor Shown to Be Most Accurate in Monitoring Cyanotic Infants
HSMN NewsFeed - 17 Jan 2007
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 7 Nov 2006
Biophan Announces William L. Holman, MD, Has Joined The MYOTECH Scientific Advisory Board
Biophan Announces William L. Holman, MD, Has Joined The MYOTECH Scientific Advisory Board
HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
HSMN NewsFeed - 24 Oct 2006
Covalon Announces Completed Acquisition of Perfusion Therapeutics' Gene Therapy Technology
Covalon Announces Completed Acquisition of Perfusion Therapeutics' Gene Therapy Technology
HSMN NewsFeed - 12 Jul 2006
Biophan Announces Key Senate Approval of $400,000 for the MYO-VAD Cardiac Assist Device
Biophan Announces Key Senate Approval of $400,000 for the MYO-VAD Cardiac Assist Device
HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
HSMN NewsFeed - 31 May 2006
MedicalCV, Inc. Submits 510(k) Application to FDA for ATRILAZE(TM) Minimally Invasive System
MedicalCV, Inc. Submits 510(k) Application to FDA for ATRILAZE(TM) Minimally Invasive System
Additional items found! 65
![Members: click here for search results from The HSMN Archive (password required)](images/ARCHIVE.png)
Members Archive contains
65 additional stories matching:
Cardiac Output
(Password required)
Cardiac Output
(Password required)